Amsterdam, the Netherlands and Cambridge, MA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the Center for Devices and Radiological Health (CDRH) of ...

The North American subsidiary of Amsterdam-based Royal Philips reached an agreement on a consent decree with the U.S. Department of Justice, representing the Food and Drug Administration, the company ...

The Food and Drug Administration (FDA) is warning consumers that some models of HeartStart automated external defibrillators (AED) may not work during a cardiac emergency. The devices, which are made ...

Amsterdam, the Netherlands –Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the Center for Devices and Radiological Health (CDRH) of the Food and Drug ...

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced today that its Emergency Care and Resuscitation (ECR) business is resuming ...

Royal Philips Electronics, a pioneer in developing treatments to combat sudden cardiac arrest, and Air France-KLM Group, one of the leading European air transport group, today announced an agreement ...

The Food and Drug Administration warned this week that thousands of Philips automated external defibrillators (AED) might not be able to deliver a needed shock in a cardiac emergency situation. The ...

Philips recently announced that it is voluntarily recalling approximately 5,400 HeartStart FR2+ automated external defibrillators (AEDs). This recall is being conducted due to the possibility of a ...

(MENAFN- GlobeNewsWire - Nasdaq) Advancements in next-gen defibrillators and rising lifestyle-related health issues amplify growth potential, despite access challenges Dublin, Aug. 28, 2025 (GLOBE ...